Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1990 Dec;87(23):9498–9502. doi: 10.1073/pnas.87.23.9498

Vaccination against tumor cells expressing breast cancer epithelial tumor antigen.

M Hareuveni 1, C Gautier 1, M P Kieny 1, D Wreschner 1, P Chambon 1, R Lathe 1
PMCID: PMC55194  PMID: 2251291

Abstract

Ninety-one percent of breast tumors aberrantly express an epithelial tumor antigen (ETA) identified by monoclonal antibody H23. Vaccinia virus recombinants expressing tumor antigens have considerable promise in the active immunotherapy of cancer, and we have evaluated the potential of vaccinia recombinants expressing the secreted (S) and cell-associated (transmembrane, T) forms of H23 ETA to elicit immunity to tumor cells expressing ETA. Tumorigenic ras-transformed Fischer rat fibroblast lines FR-S and FR-T, expressing the S or T form of H23 ETA, respectively, were constructed for use in challenge experiments. Expression of H23 ETA in these lines was confirmed by Western blotting and immunofluorescence. When challenged by subcutaneous seeding of tumor cells, 97% (FR-S) and 91% (FR-T) of syngeneic Fischer rats rapidly developed tumors that failed to regress. Vaccination with recombinant vaccinia virus expressing ETA-T prior to challenge prevented tumor development in 82% of animals seeded with FR-T cells but in only 61% of animals seeded with FR-S. The vaccinia recombinant expressing the S form was a less effective immunogen, and vaccination protected only 29-30% of animals from developing tumors upon challenge with either FR-S or -T cells. The increased immunogenicity of the recombinant expressing ETA-T was reflected in elevated levels of ETA-reactive antibody in vaccinated animals, confirming that secreted antigens expressed from vaccinia virus are less effective immunogens than their membrane-associated counterparts.

Full text

PDF
9498

Images in this article

9499Image
on p.9499
9499Image
on p.9499
9500Image
on p.9500
9500Image
on p.9500
9500Image
on p.9500
9500Image
on p.9500
9500Image
on p.9500
9500Image
on p.9500

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe M., Kufe D. Effects of maturational agents on expression and secretion of two partially characterized high molecular weight milk-related glycoproteins in MCF-7 breast carcinoma cells. J Cell Physiol. 1986 Jan;126(1):126–132. doi: 10.1002/jcp.1041260117. [DOI] [PubMed] [Google Scholar]
  2. Bernards R., Destree A., McKenzie S., Gordon E., Weinberg R. A., Panicali D. Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector. Proc Natl Acad Sci U S A. 1987 Oct;84(19):6854–6858. doi: 10.1073/pnas.84.19.6854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bramwell M. E., Bhavanandan V. P., Wiseman G., Harris H. Structure and function of the Ca antigen. Br J Cancer. 1983 Aug;48(2):177–183. doi: 10.1038/bjc.1983.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Burchell J., Durbin H., Taylor-Papadimitriou J. Complexity of expression of antigenic determinants, recognized by monoclonal antibodies HMFG-1 and HMFG-2, in normal and malignant human mammary epithelial cells. J Immunol. 1983 Jul;131(1):508–513. [PubMed] [Google Scholar]
  5. Ceriani R. L., Peterson J. A., Blank E. W. Variability in surface antigen expression of human breast epithelial cells cultured from normal breast, normal tissue peripheral to breast carcinomas, and breast carcinomas. Cancer Res. 1984 Jul;44(7):3033–3039. [PubMed] [Google Scholar]
  6. Colbère-Garapin F., Horodniceanu F., Kourilsky P., Garapin A. C. A new dominant hybrid selective marker for higher eukaryotic cells. J Mol Biol. 1981 Jul 25;150(1):1–14. doi: 10.1016/0022-2836(81)90321-1. [DOI] [PubMed] [Google Scholar]
  7. Dalianis T. Studies on the polyoma virus tumor-specific transplantation antigen (TSTA). Adv Cancer Res. 1990;55:57–85. doi: 10.1016/s0065-230x(08)60468-6. [DOI] [PubMed] [Google Scholar]
  8. Estin C. D., Stevenson U. S., Plowman G. D., Hu S. L., Sridhar P., Hellström I., Brown J. P., Hellström K. E. Recombinant vaccinia virus vaccine against the human melanoma antigen p97 for use in immunotherapy. Proc Natl Acad Sci U S A. 1988 Feb;85(4):1052–1056. doi: 10.1073/pnas.85.4.1052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gautier C., Mehtali M., Lathe R. A ubiquitous mammalian expression vector, pHMG, based on a housekeeping gene promoter. Nucleic Acids Res. 1989 Oct 25;17(20):8389–8389. doi: 10.1093/nar/17.20.8389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gendler S. J., Burchell J. M., Duhig T., Lamport D., White R., Parker M., Taylor-Papadimitriou J. Cloning of partial cDNA encoding differentiation and tumor-associated mucin glycoproteins expressed by human mammary epithelium. Proc Natl Acad Sci U S A. 1987 Sep;84(17):6060–6064. doi: 10.1073/pnas.84.17.6060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gendler S., Taylor-Papadimitriou J., Duhig T., Rothbard J., Burchell J. A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. J Biol Chem. 1988 Sep 15;263(26):12820–12823. [PubMed] [Google Scholar]
  12. Graham F. L., van der Eb A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973 Apr;52(2):456–467. doi: 10.1016/0042-6822(73)90341-3. [DOI] [PubMed] [Google Scholar]
  13. Hareuveni M., Tsarfaty I., Zaretsky J., Kotkes P., Horev J., Zrihan S., Weiss M., Green S., Lathe R., Keydar I. A transcribed gene, containing a variable number of tandem repeats, codes for a human epithelial tumor antigen. cDNA cloning, expression of the transfected gene and over-expression in breast cancer tissue. Eur J Biochem. 1990 May 20;189(3):475–486. doi: 10.1111/j.1432-1033.1990.tb15512.x. [DOI] [PubMed] [Google Scholar]
  14. Herlyn D., Ross A. H., Koprowski H. Anti-idiotypic antibodies bear the internal image of a human tumor antigen. Science. 1986 Apr 4;232(4746):100–102. doi: 10.1126/science.3952496. [DOI] [PubMed] [Google Scholar]
  15. Hilkens J., Buijs F., Hilgers J., Hageman P., Calafat J., Sonnenberg A., van der Valk M. Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors. Int J Cancer. 1984 Aug 15;34(2):197–206. doi: 10.1002/ijc.2910340210. [DOI] [PubMed] [Google Scholar]
  16. Hoover H. C., Jr, Surdyke M. G., Dangel R. B., Peters L. C., Hanna M. G., Jr Prospectively randomized trial of adjuvant active-specific immunotherapy for human colorectal cancer. Cancer. 1985 Mar 15;55(6):1236–1243. doi: 10.1002/1097-0142(19850315)55:6<1236::aid-cncr2820550616>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  17. Johnson V. G., Schlom J., Paterson A. J., Bennett J., Magnani J. L., Colcher D. Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3. Cancer Res. 1986 Feb;46(2):850–857. [PubMed] [Google Scholar]
  18. Keydar I., Chou C. S., Hareuveni M., Tsarfaty I., Sahar E., Selzer G., Chaitchik S., Hizi A. Production and characterization of monoclonal antibodies identifying breast tumor-associated antigens. Proc Natl Acad Sci U S A. 1989 Feb;86(4):1362–1366. doi: 10.1073/pnas.86.4.1362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kieny M. P., Gautier C., Tomasetto C., Kuhn I., Hareuveni M., Clertant P., Lathe R. Vaccination against polyoma virus (PyV) tumors using vaccinia-PyV recombinants: a major tumor-specific transplantation antigen (TSTA) epitope resides within the C-terminal segment of middle-T protein. Int J Cancer. 1990 Jan 15;45(1):185–189. doi: 10.1002/ijc.2910450133. [DOI] [PubMed] [Google Scholar]
  20. Kieny M. P., Lathe R., Rivière Y., Dott K., Schmitt D., Girard M., Montagnier L., Lecocq J. Improved antigenicity of the HIV env protein by cleavage site removal. Protein Eng. 1988 Sep;2(3):219–225. doi: 10.1093/protein/2.3.219. [DOI] [PubMed] [Google Scholar]
  21. Lan M. S., Finn O. J., Fernsten P. D., Metzgar R. S. Isolation and properties of a human pancreatic adenocarcinoma-associated antigen, DU-PAN-2. Cancer Res. 1985 Jan;45(1):305–310. [PubMed] [Google Scholar]
  22. Lathe R., Kieny M. P., Gerlinger P., Clertant P., Guizani I., Cuzin F., Chambon P. Tumour prevention and rejection with recombinant vaccinia. 1987 Apr 30-May 6Nature. 326(6116):878–880. doi: 10.1038/326878a0. [DOI] [PubMed] [Google Scholar]
  23. Lee V. K., Harriott T. G., Kuchroo V. K., Halliday W. J., Hellström I., Hellström K. E. Monoclonal antiidiotypic antibodies related to a murine oncofetal bladder tumor antigen induce specific cell-mediated tumor immunity. Proc Natl Acad Sci U S A. 1985 Sep;82(18):6286–6290. doi: 10.1073/pnas.82.18.6286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Magnani J. L., Steplewski Z., Koprowski H., Ginsburg V. Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. Cancer Res. 1983 Nov;43(11):5489–5492. [PubMed] [Google Scholar]
  25. Matrisian L. M., Glaichenhaus N., Gesnel M. C., Breathnach R. Epidermal growth factor and oncogenes induce transcription of the same cellular mRNA in rat fibroblasts. EMBO J. 1985 Jun;4(6):1435–1440. doi: 10.1002/j.1460-2075.1985.tb03799.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. McKenzie I. F., Xing P. X. Mucins in breast cancer: recent immunological advances. Cancer Cells. 1990 Mar;2(3):75–78. [PubMed] [Google Scholar]
  27. Meneguzzi G., Kieny M. P., Lecocq J. P., Chambon P., Cuzin F., Lathe R. Vaccinia recombinants expressing early bovine papilloma virus (BPV1) proteins: retardation of BPV1 tumour development. Vaccine. 1990 Jun;8(3):199–204. doi: 10.1016/0264-410x(90)90045-n. [DOI] [PubMed] [Google Scholar]
  28. Moss B., Flexner C. Vaccinia virus expression vectors. Annu Rev Immunol. 1987;5:305–324. doi: 10.1146/annurev.iy.05.040187.001513. [DOI] [PubMed] [Google Scholar]
  29. Nepom G. T., Nelson K. A., Holbeck S. L., Hellström I., Hellström K. E. Induction of immunity to a human tumor marker by in vivo administration of anti-idiotypic antibodies in mice. Proc Natl Acad Sci U S A. 1984 May;81(9):2864–2867. doi: 10.1073/pnas.81.9.2864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Price M. R., Edwards S., Robins R. A., Hilgers J., Hilkens J., Baldwin R. W. Epitopes with diagnostic and prognostic significance co-expressed on a human breast carcinoma-associated antigen. Eur J Cancer Clin Oncol. 1986 Jan;22(1):115–117. doi: 10.1016/0277-5379(86)90351-2. [DOI] [PubMed] [Google Scholar]
  31. Sharon R., Naor D. The isolation of immunogenic molecular entities from immunogenic and nonimmunogenic tumor homogenates by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Cancer Immunol Immunother. 1984;18(3):203–208. doi: 10.1007/BF00205512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Siddiqui J., Abe M., Hayes D., Shani E., Yunis E., Kufe D. Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen. Proc Natl Acad Sci U S A. 1988 Apr;85(7):2320–2323. doi: 10.1073/pnas.85.7.2320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Talarico D., Ittmann M., Balsari A., Delli-Bovi P., Basch R. S., Basilico C. Protection of mice against tumor growth by immunization with an oncogene-encoded growth factor. Proc Natl Acad Sci U S A. 1990 Jun;87(11):4222–4225. doi: 10.1073/pnas.87.11.4222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wallack M. K., McNally K. R., Leftheriotis E., Seigler H., Balch C., Wanebo H., Bartolucci A. A., Bash J. A. A Southeastern Cancer Study Group phase I/II trial with vaccinia melanoma oncolysates. Cancer. 1986 Feb 1;57(3):649–655. doi: 10.1002/1097-0142(19860201)57:3<649::aid-cncr2820570342>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  35. Wallack M. K., McNally K., Michaelides M., Bash J., Bartolucci A., Siegler H., Balch C., Wanebo H. A phase I/II SECSG (Southeastern Cancer Study Group) pilot study of surgical adjuvant immunotherapy with vaccinia melanoma oncolysates (VMO). Am Surg. 1986 Mar;52(3):148–151. [PubMed] [Google Scholar]
  36. Wallack M. K., Steplewski Z., Koprowski H., Rosato E., George J., Hulihan B., Johnson J. A new approach in specific, active immunotherapy. Cancer. 1977 Feb;39(2):560–564. doi: 10.1002/1097-0142(197702)39:2<560::aid-cncr2820390227>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  37. Wigler M., Pellicer A., Silverstein S., Axel R. Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor. Cell. 1978 Jul;14(3):725–731. doi: 10.1016/0092-8674(78)90254-4. [DOI] [PubMed] [Google Scholar]
  38. Wreschner D. H., Hareuveni M., Tsarfaty I., Smorodinsky N., Horev J., Zaretsky J., Kotkes P., Weiss M., Lathe R., Dion A. Human epithelial tumor antigen cDNA sequences. Differential splicing may generate multiple protein forms. Eur J Biochem. 1990 May 20;189(3):463–473. doi: 10.1111/j.1432-1033.1990.tb15511.x. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES